Bi-directional regulation between adiponectin and plasminogen activator-inhibitor-1 in 3T3-L1 cells

In Vivo

Volumn 28, Issue 1, 2014, Pages 13-19

  Komiya, Masami ^a   Fujii, Gen ^a   Takahashi, Mami ^a   Shimura, Misato ^a,b   Noma, Nobuharu ^a,b   Shimizu, Satomi ^a,c   Onuma, Wakana ^a,b   Mutoh, Michihiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c TOYO UNIVERSITY   (Japan)

Author keywords

Adiponectin; AMPK; Pai 1; PPAR; Pre adipocyte

Indexed keywords

ADIPONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEASE NEXIN I; SERPINE2 PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; AMPK; ANIMAL; BIOSYNTHESIS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAI-1; PRE-ADIPOCYTE;

ADIPONECTIN; AMPK; PAI-1; PPAR; PRE-ADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; SERPIN E2;

EID: 84906927708     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Scherer PE, Williams S, Fogliano M, Baldini G and Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749, 1995.
2. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC and Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133, 2001.
3. Haluzík M, Parízková J and Haluzík MM: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53: 123-129, 2004.
4. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T and Matsuzawa Y: Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476, 1999.
5. Wei EK, Giovannucci E, Fuchs CS, Willett WC and Mantzoros CS: Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study. J Nat Cancer Inst 97: 1688-1694, 2005.
6. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, Saito T, Togashi H, Nakamura T, Matsuzawa Y and Kawata S: Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: Evidence for participation of insulin resistance. Clin Cancer Res 11: 3642-3646, 2005.
7. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R and Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003.
8. Kadowaki T and Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451, 2005.
9. Luo Z, Saha AK, Xiang X and Ruderman NB: AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26: 69-76, 2005.
10. Mutoh M, Teraoka N, Takasu S, Takahashi M, Onuma K, Yamamoto M, Kubota N, Iseki T, Kadowaki T, Sugimura T and Wakabayashi K: Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. Gastroenterology 140: 2000-2008, 2011.
11. Leik CE, Su EJ, Nambi P, Crandall DL and Lawrence DA: Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis. J Thromb Haemost 4: 2710-2715, 2006.
12. Kortlever RM and Bernards R: Senescence, wound healing and cancer: The PAI-1 connection. Cell Cycle 5: 2697-2703, 2006.
13. Nilsson L, Banfi C, Diczfalusy U, Tremoli E, Hamsten A and Eriksson P: Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 18: 1679-1685, 1998.
14. Sawdey MS and Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-β. J Clin Invest 88: 1346-1353, 1991.
15. Kortlever RM, Higgins PJ and Bernards R: Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 8: 877-884, 2006.
16. Ferran C, Millan MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH and Winkler H: Inhibition of NF-kB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun 214: 212-223, 1995.
17. He W, Tan R, Dai C, Li Y, Wang D, Hao S, Kahn M and Liu Y: Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of WNT/β-catenin signaling. J Biol Chem 285: 24665-24675, 2010.
18. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y and Kadowaki T: Adiponectin stimulates AMPactivated protein kinase in the hypothalamus and increases food intake. Cell Metab 6: 55-68, 2007.
19. Tang QQ and Lane MD: Adipogenesis: From stem cell to adipocyte. Annu Rev Biochem 81: 715-36, 2012.
20. Ueno T, Teraoka N, Takasu S, Nakano K, Takahashi M, Yamamoto M, Fujii G, Komiya M, Yanaka A, Wakabayashi K and Mutoh M: Suppressive effect of pioglitazone, a PPARγligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice. Asian Pac J Cancer Prev 13: 4067-4073, 2012.
21. Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB and Ma LJ: Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab 290: E103-E113, 2006.
22. Dagon Y, Avraham Y and Berry EM: AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes. Biochem Biophys Res Commun 340: 43-47, 2006.
23. Mutoh M, Niho N, Komiya M, Takahashi M, Ohtsubo R, Nakatogawa K, Ueda K, Sugimura T and Wakabayashi K: Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Carcinogenesis 29: 824-829, 2008.